Notices

April

April 30, 2026
In Memoriam – Dr. Juliet Daniel

November

November 12, 2025
Update on standing committee motion – disaggregated data request

Dear colleagues,

I'm writing to share an update on the Standing Committee on Science and Research's October 1 motion requesting that the federal granting agencies submit a large volume of disaggregated data related to tri-agency-funded research and researchers. This initial motion called for the agencies to submit individualized EDI data, application details, peer review scores and notes and information on both successful and unsuccessful applicants.

While CIHR already discloses key details about funded applications, such as applicant names, affiliations, project summaries and funding amounts, the breadth of the motion raised concerns across the research community, culminating in a letter-writing campaign that garnered more than 5,000 signatures.

Amended motion

On November 5, the standing committee amended its motion, requesting only aggregated, anonymized data.

This amendment provides reassurance that the funding agencies' obligations under the Privacy Act and our commitment to safeguarding researchers' information and the integrity of the peer review process were understood by the committee.

What the funding agencies did release

By the committee's deadline of November 4 for its original motion, we provided details on funded applications that are already disclosed online—including researcher names, afiliations, project summaries and funding amounts—and aggregated EDI data for funded and unfunded applications so that individuals cannot be identified.

Please do not hesitate to reach out with any questions. I want to thank each and every one of you for your services to peer review and your dedication to the health research enterprise.

Sincerely,

Adrian Mota,
Acting Vice-President, Research – Programs
Canadian Institutes of Health Research

October

October 8, 2025
In Memoriam – Dr. Balfour Mount

It is with profound sadness that we learn of the passing of Dr. Balfour Mount.

Widely regarded as the father of end-of-life care, Dr. Mount began his medical career as a urologist and a surgical oncologist. Beginning in the 1970s, Dr. Mount became interested in the needs of the terminally ill and their families, and began travelling around the world to explain and promote palliative care – a term he coined. In both his research and medical practice, he combined scientific excellence with deep compassion and an abiding appreciation for the importance of alleviating suffering.

A medical graduate of Queen's University, his work earned him many accolades, including the American Academy of Hospice and Palliative Medicine Humanities Award (2013), the Queen Elizabeth II Diamond Jubilee Medal (2012), Officer of the Order of Canada (2004), and Officer of the Order of Quebec (1988).

All of us at CIHR express our deep gratitude for Dr. Mount's pioneering contributions to health care, and offer our sincere condolences to his family and friends.

May

May 2, 2025
In Memoriam – Dr. Henry Friesen

January

January 20, 2025
Multifactor authentication is coming to the Canadian Common CV (CCV) in March 2025

Multifactor authentication will be introduced to the CCV in March 2025. The multifactor authentication process will be triggered each time a user signs in to the CCV. To access the application, users will be required to enter a code that is sent to the email address connected to their CCV account.

It is important that everyone with a CCV account confirms that they have access to the email address connected to their account before March 2025. This will ensure users have uninterrupted access to the CCV, minimizing the need for assistance from the Contact Centre.

December

December 13, 2024
My CIHR Profile is now live in ResearchNet.

The My CIHR Profile is a new self-serve tool that will allow ResearchNet users to view, input, and update their personal information as needed. The first time you log into your ResearchNet account on or after December 13, you will be taken directly to your My CIHR Profile to validate your personal information. Your My CIHR Profile can also be accessed by clicking on your name in the top right-hand corner of the ResearchNet screen.

If you have any questions, please reach out to the Contact Centre.

December 10, 2024
My CIHR Profile coming to ResearchNet on December 13, 2024

CIHR will be implementing My CIHR Profile in ResearchNet on December 13, 2024. The My CIHR Profile is a new self-serve tool that will allow ResearchNet users to view, input, and update their personal information as needed. The first time you log into your ResearchNet account on or after December 13, you will be taken directly to your My CIHR Profile to validate your personal information. Your My CIHR Profile can also be accessed by clicking on your name in the top right-hand corner of the ResearchNet screen.

For questions, please reach out to the Contact Centre.

November

November 27, 2024
Bouchard (Phoenix pay system) class action:

A settlement has been reached in the Bouchard class action against the Government of Canada. Consult the first notification to class members to learn more about the settlement, who's included in the class action, how to participate in the hearing to approve the settlement, or how to opt out of the class action.

September

September 18, 2024
In memoriam: Dr. Philip Branton

We are saddened to learn of the passing of esteemed cancer researcher Dr. Philip Branton.

Dr. Branton was a cancer virologist with Université de Sherbrooke, McMaster University, and McGill University. When CIHR was created in 2000, Dr. Branton was appointed the inaugural Scientific Director of the Institute of Cancer Research. While serving in this role, he founded the Canadian Cancer Research Alliance, an organization that works strategically to coordinate and collaborate on most of the cancer research conducted in Canada. Dr. Branton was a natural at bringing people together in support of a common cause, and he used this collaborative approach to support research to uncover the factors that cause cancer and discover better treatments to improve patient and survivor outcomes.

Known for his kindness, humour, and leadership ability, Dr. Branton received many prestigious appointments and awards during his career, including being named a Member of the Royal Society of Canada, his reception of the Queen Elizabeth II Diamond Jubilee Medal, and becoming an Officer of the Order of Canada.

All of us at the Canadian Institutes of Health Research offer our deepest condolences to Dr. Branton's family and friends.